卵巢癌是妇科常见的恶性肿瘤,也是死亡率最高的妇科肿瘤。由于其易扩散的生物学行为,起病部位较隐匿以及缺乏有效的早期诊断方法,约70%左右的患者在就诊时已届晚期(Ⅲ期~Ⅳ期)。患者5年生存率滞留在19%~40%左右~([1,2])。目前临床上常用的治疗方案为初次肿瘤细胞减灭术(primary debulking surgery,PDS),意即最大限度地切除盆腹腔内的肿瘤病灶,尽可能使残留肿瘤病灶 Ovarian cancer is a common gynecological malignancy, but also the highest mortality of gynecological tumors. About 70% of patients have advanced stage (stage III to IV) at the time of their visit due to their predilection-prone biological behavior, occult onset and lack of effective early diagnosis. The 5-year survival rate of patients stays in 19% ~ 40% ~ ([1,2]). At present, the commonly used clinical treatment plan is primary debulking surgery (PDS), which means to remove the tumor focus in the pelvic cavity as much as possible and make the residual tumor focus